1H NMR investigations on the solution structure of the oligonucleotide 5′-d(ACCT5GATGT)-3′/5′-d(ACATCA5GGT)-3′ and its interaction with tallimustine

(Note: The full text of this document is currently only available in the PDF Version )

Enzio Ragg, Stefania Mazzini, Rita Bortolini, Nicola Mongelli and Roberto D’Alessio


Abstract

The conformation of the DNA duplex 5′-d(ACCT5GATGT)-3′/5′-(ACATCA5GGT)-3′ has been studied by means of 2D 1H NMR and restrained molecular mechanics and dynamics calculations. This sequence contains the tract ‘T4GA’, which has previously been proved to be the recognition sequence of tallimustine, a distamycin-A analogue, containing a nitrogen mustard moiety and with interesting anti-leukemia properties. The tridecamer has been found to possess a B-type DNA conformation with local variations in the helical parameters which may be related to the sequence. Guanine in position 9, a residue supposed to be a key point for tallimustine recognition, is at the end of a homopyrimidinic tract where the propeller twist is found to decrease down to 9° at the flanking residue A10. Analysis of the minor groove geometry has revealed an increase of the width up to G9 and a return to average values at the level of residues A10–C18. The reversible interaction of this oligonucleotide with tallimustine has also been investigated by NMR and UV spectroscopy. The association constant Ka is 2 × 107 dm3 mol–1. The off-rate constant is 1.5 ± 0.5 s–1 as measured by NOESY-exchange experiments performed at R = [drug]/[DNA] = 0.5. A multiple mode of binding of tallimustine with the oligomer has been detected by analysis of 1H NMR spectra; however, the chemical shift analysis and several inter-molecular NOE interactions observed at low drug∶DNA ratios have provided sufficient structural information to define the major orientation of the drug in the minor groove. The positively charged amidinic moiety is situated at the beginning of the AT-rich region and the phenyl group resides close to the T8∶A19 base pair. The specificity of interaction of tallimustine depends on a favourable steric interaction at the T8G9A10 tract, as a result of the widening of the minor groove allowing accommodation of the phenyl moiety in the floor of the groove. Under the conditions applied in the NMR studies, negligible alkylation has been detected by HPLC measurements. However, after nine days of incubation at T = 37 °C several peaks corresponding to alkylation products are detected giving further indications of a multiple mode of binding of tallimustine with the oligonucleotide.


References

  1. F. C. Giuliani, B. Barbieri, G. Pezzoni, E. Lazzari, F. M. Arcamone and N. Mongelli, Proc. Am. Ass. Cancer Res., 1988, 29, 329 Search PubMed.
  2. G. Pezzoni, M. Grandi, G. Biasoli, L. Capolongo, D. Ballinari, F. C. Giuliani, B. Barbieri, A. Pastori, E. Pesenti, N. Mongelli and F. Spreafico, Br. J. Cancer, 1991, 64, 1047 CAS.
  3. R. D'Alessio, C. Geroni, G. Biasoli, E. Pesenti, M. Grandi and N. Mongelli, Bioorg. Med. Chem. Lett., 1994, 4, 1467 CrossRef CAS.
  4. D. Abigerges, G. P. Armand, L. Da Costa, E. Fadel, D. Mignard, C. Lhomme, M. G. Zurlo and D. Gandia, Proc. Am. Ass. Cancer Res., 1993, 34, 1589 Search PubMed.
  5. F. M. Arcamone, F. Animati, B. Barbieri, E. Configliacchi, R. D'Alessio, C. Geroni, F. C. Giuliani, E. Lazzari, M. Menozzi, N. Mongelli, N. S. Penco and M. A. Verini, J. Med. Chem., 1989, 32, 774 CrossRef CAS.
  6. C. L. Propst and T. J. Perun, Nucleic Acid Targeted Drug Design, Marcel Dekker, New York, 1992, p. 303 Search PubMed.
  7. M. D. Wyatt, M. Lee, B. J. Gabiras, R. L. Souhami and J. A. Hartley, Biochemistry, 1995, 34, 13 034 CrossRef CAS.
  8. M. Broggini, H. M. Coley, N. Mongelli, E. Pesenti, M. D. Wyatt, J. A. Hartley and M. D'Incalci, Nucleic Acids Res., 1995, 23, 81 CAS.
  9. C. Szezylik, T. Skorski, N. C. Nicoladeis, L. Manzella, L. Malaguarnera, D. Venturelli, A. M. Gewirtz and B. Calabretta, Science, 1991, 253, 562.
  10. F. X. Mahon, F. Belloc and J. Reiffers, Lancet, 1993, 341, 566 CAS.
  11. J. Jeener, B. M. Meier, P. Bachmann and R. R. Ernst, J. Chem. Phys., 1979, 71, 4546 CrossRef CAS.
  12. S. Macura and R. R. Ernst, Mol. Phys., 1980, 41, 95 CAS.
  13. L. Braunschweiler and R. R. Ernst, J. Magn. Res., 1983, 53, 521 CAS.
  14. G. Otting, R. Grutter, W. Leupin, C. Minganti, K. N. Ganesh, B. S. Sproat, M. J. Gait and K. Wütrich, Eur. J. Biochem., 1987, 166, 215 CAS.
  15. A. C. Wang, S. G. Kim, P. F. Flynn, E. Sletten and B. R. Reid, J. Magn. Reson., 1992, 100, 358 CAS.
  16. K. Wüthrich, NMR of Proteins and Nucleic Acids, Wiley, New York, 1986 Search PubMed.
  17. P. Rajagopal, D. E. Gilbert, G. A. van der Marel, J. H. van boom and J. Feigon, J. Magn. Reson., 1988, 78, 526 CAS.
  18. R. Boelens, T. M. G. Koning, G. A. van der Marel, J. H. van Boom and R. Kaptein, J. Magn. Reson., 1989, 82, 290 CAS.
  19. A. Saran, D. Perahia and B. Pullman, Theor. Chim. Acta (Berlin), 1973, 30, 31 CAS.
  20. R. E. Dickerson and H. R. Drew, J. Mol. Biol., 1981, 149, 761 CrossRef CAS.
  21. D. G. Gorenstein, Chem. Rev., 1994, 94, 1315 CrossRef CAS.
  22. R. E. Dickerson, J. Mol. Biol., 1983, 166, 419 CAS.
  23. C. R. Calladine, J. Mol. Biol., 1982, 161, 343 CrossRef CAS.
  24. M. Katahira, H. Sugeta, Y. Kyogoku, S. Fujisawa and R. Tomita, Nucleic Acids Res., 1988, 16, 8619 CAS.
  25. M. Katahira, H. Sugeta and Y. Kyogoku, Nucleic Acids Res., 1990, 18, 613 CAS.
  26. M. Coll, C. A. Frederick, A. H. J. Wang and A. Rich, Proc. Natl. Acad. Sci. USA, 1987, 84, 8385 CAS.
  27. W. Saenger, Principles of Nucleic Acid Structure, Springer-Verlag, New York, 1984. p. 266 and references therein Search PubMed.
  28. (a) K. Zakrzewska and B. Pullman, Nucleic Acids Res., 1983, 11, 8841 CAS; (b) R. Lavery, A. Pullman and B. Pullman, Theor. Chim. Acta, 1982, 62, 93 CAS; (c) K. W. Kohn, J. A. Hartley and W. B. Mattes, Nucleic Acids Res., 1987, 15, 10 531 CAS.
  29. D. Neuhaus and M. P. Williamson, The Nuclear Overhauser Effect in Structural and Conformational Analysis, VCH, New York, 1986, p. 175 Search PubMed.
  30. S. Mazzini, G. Musco and E. Ragg, Magn. Reson. Chem., 1994, 32, 139 CAS.
  31. J. G. Pelton and D. Wemmer, Biochemistry, 1988, 27, 8088 CrossRef CAS.
  32. T. J. Dwyer, B. H. Geierstanger, Y. Bathini, J. W. Lown and D. E. Wemmer, J. Am. Chem. Soc., 1992, 114, 5911 CrossRef CAS.
  33. J. G. Pelton and D. E. Wemmer, J. Am. Chem. Soc., 1990, 112, 1393 CrossRef CAS.
  34. R. E. Klevit, D. E. Wemmer and B. Reid, Biochemistry, 1986, 25, 3296 CrossRef CAS.
  35. P. G. Schutz and P. B. Dervan, J. Am. Chem. Soc., 1983, 105, 7748 CrossRef.
  36. R. P. Hertzberg and P. B. Dervan, J. Am. Chem. Soc., 1982, 104, 313 CrossRef CAS.
  37. (a) M. L. Kopka, C. Yoon, D. Goodsell, P. Pjura and R. E. Dickerson, J. Mol. Biol., 1985, 183, 553 CrossRef CAS; (b) M. L. Kopka, C. Yoon, D. Goodsell, P. Pjura and R. E. Dickerson, Proc. Natl. Acad. Sci. USA, 1985, 82, 1376 CAS.
  38. M. Coll, J. Aymami, G. A. van der Marel, J. H. van Boom, A. Rich and A. H. J. Wang, Biochemistry, 1989, 28, 310 CrossRef CAS.
  39. A. Blaskò, K. A. Browne and T. C. Bruice, J. Am. Chem. Soc., 1994, 116, 3726 CrossRef CAS.
  40. (a) L. A. Marky and K. J. Breslauer, Biopolymers, 1987, 26, 1601 CrossRef CAS; (b) D. M. Crothers, Biopolymers, 1971, 10, 2147 CAS.
  41. K. J. Breslauer, R. Frank, H. Blocker and L. A. Marky, Proc. Natl. Acad. Sci. USA, 1986, 83, 3746 CAS.
  42. (a) L. A. Marky and K. J. Breslauer, Proc. Natl. Acad. Sci. USA, 1987, 84, 4359 CAS; (b) K. J. Breslauer, D. P. Remeta, W. Y. Chou, R. Ferrante, J. Curry, D. Zaunczkowski, J. G. Snyder and L. A. Marky, Proc. Natl. Acad. Sci. USA, 1987, 84, 8922 CAS.
  43. E. L. Fish, M. L. Lane and J. N. Vournakis, Biochemistry, 1988, 27, 6026 CrossRef CAS.
  44. M. Fontana, M. Lestingi, C. Mondello, A. Braghetti, A. Montecucco and G. Ciarrocchi, Anti-Cancer Drug Des., 1992, 7, 131 Search PubMed.
  45. C. J. O'Connor, W. A. Denny, J. Y. Fan, G. Lance Gravatt, B. A. Grigor and D. J. McLennan, J. Chem. Soc., Perkin Trans. 2, 1991, 1933 RSC.
  46. J. A. Hartley, S. M. Forrow and R. L. Souhami, Biochemistry, 1990, 29, 2985 CrossRef CAS.
  47. T. A. Gourdie, K. K. Valu, G. Lance Gravatt, T. J. Boritzki, B. C. Baguley, L. P. G. Wakelin, W. R. Wilson, P. D. Woodgate and W. A. Denny, J. Med. Chem., 1990, 33, 1177 CrossRef CAS.
Click here to see how this site uses Cookies. View our privacy policy here.